Innovent Shares Climb After $350 Million Upfront From New Eli Lilly Collaboration
Innovent Biologics shares jumped in Hong Kong after the company announced a new development partnership with Eli Lilly focused on oncology and immunology. Innovent will receive a $350 million upfront payment and could collect up to $8.5 billion in additional payments tied to future milestones. The deal is the seventh collaboration between the two f…